ABSTRACT Background and aims: The albumin-to-globulin ratio (AGR) has been used to predict severity and mortality in infectious diseases. The aim of this study is
ABSTRACT Objectives: To describe the prevalence of risks of bias in randomised trials of therapeutic interventions for COVID-19. Study design and setting Systematic review and risk
ABSTRACT Despite the great success of the administered vaccines against SARS-CoV-2, the virus can still spread, as evidenced by the current circulation of the highly
ABSTRACT Background and aims: The albumin-to-globulin ratio (AGR) has been used to predict severity and mortality in infectious diseases. The aim of this study is
ABSTRACT Objectives: To describe the prevalence of risks of bias in randomised trials of therapeutic interventions for COVID-19. Study design and setting Systematic review and risk
ABSTRACT Despite the great success of the administered vaccines against SARS-CoV-2, the virus can still spread, as evidenced by the current circulation of the highly